Martin Wax


Dr. Martin Wax is a clinician-scientist and currently the CEO and Board Chairman, Mimetogen Pharmaceuticals, Inc. located in Montreal, Canada, and Co-Founder, PanOptica, Inc. 

He was the Chief Medical Officer and Executive Vice-President of R&D, at PanOptica, Inc., a private US biotechnology company specializing in ophthalmic pharmaceuticals from 2009-2020. Prior to that he was Vice President of R&D and Head of Ophthalmology Discovery Research and Preclinical Sciences at Alcon Laboratories from 2003-2008. Dr. Wax has authored more than 200 scientific and clinical publications focusing on glaucoma pharmacology and mechanisms of neuronal cell death in glaucoma.

scroll to up
Sign up to receive company news alerts